Othon Wiltz
Dr. Wiltz's clinical interests include inflammatory bowel disease with special focus on fistulizing Crohn’s disease and surgical management in patients on biologics; rectal cancer care within a multidisciplinary setting; robotic colon and rectal surgery; and the treatment of benign anorectal conditions in ambulatory settings.
Dr. Wiltz’s research interests include the correlation of the genetic footprints in Crohn’s patients with fistulizing disease, rectal cancer genetic profiles as related to response to neoadjuvant chemotherapy and chemoradiation therapy, the immune modulation of response of colon and rectal cancer to adjuvant therapy and studying the pre-habilitation of surgical patients with both benign and malignant diseases.
<p>Othon Wiltz, MD, FACS, FASCRS, is a colon and rectal surgeon and Assistant Professor, Surgery at Montefiore Einstein. His clinical interests include inflammatory bowel disease with special focus on fistulizing Crohn’s disease and surgical management in patients on biologics; rectal cancer care within a multidisciplinary setting; robotic colon and rectal surgery; and the treatment of benign anorectal conditions in ambulatory settings.</p><p>After receiving his Bachelor of Arts in natural sciences at Johns Hopkins in 1981, Dr. Wiltz attended the College of Physicians and Surgeons at Columbia University, earning his Doctor of Medicine in 1985. He then went on to simultaneously pursue his general surgery residency at Deaconess/Beth Israel Hospital and a two-year surgical oncology fellowship at the Dana Farber Cancer Institute in Boston, completing these in 1992. He completed his colon and rectal surgery fellowship in 1993 at the University of Minnesota. In 2009, he earned his Master of Bioethics from the University of Navarra.</p><p>Dr. Wiltz’s research interests include the correlation of the genetic footprints in Crohn’s patients with fistulizing disease, rectal cancer genetic profiles as related to response to neoadjuvant chemotherapy and chemoradiation therapy, the immune modulation of response of colon and rectal cancer to adjuvant therapy and studying the pre-habilitation of surgical patients with both benign and malignant diseases. His research has been published in many peer-reviewed journals and presented nationally and internationally.</p><p>Dr. Wiltz is board certified in general surgery and colon and rectal surgery. He is a member of several professional memberships including the American College of Surgeons, the American Society of Colon and Rectal Surgeons, the Society of Gastrointestinal and Endoscopic Surgeons and the American Medical Association.</p>